Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1256.
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2026 · second_quarter · Q2
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1256.
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1256.
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1256.
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1256.
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R 1256.
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S.625
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S. 625.
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S.625
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade. H.R.1108 and S.625.
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1108 and S. 625.
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S. 625.
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade. H.R. 1108 and S.625.
Family Smoking Prevention and Tobacco Control Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissible restrictions on trade. H.R. 1108 and S. 625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S. 625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S.625
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissible restrictions on trade. H.R. 1108 and S. 625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade. H.R. 1108 and S.625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S. 625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1108 and S. 625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
To ensure that proposed FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade. H.R.1108 and S.625.
Access to Capital for Haiti's Development Act
Client: SPECIALTY TOBACCO COUNCIL INC · Firm: SPECIALTY TOBACCO COUNCIL, INC.
FDA regulation of tobacco products, H.R. 1108, S.625
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2026 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2025 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2025 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2025 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2025 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2025 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2024 · fourth_quarter · Q4
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2024 · third_quarter · Q3
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2024 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2024 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2023 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2023 · third_quarter · Q3
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2023 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2023 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO- permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2022 · fourth_quarter · Q4
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2022 · third_quarter · Q3
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2022 · second_quarter · Q2
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2022 · first_quarter · Q1
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2021 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2021 · third_quarter · Q3
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2021 · second_quarter · Q2
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2021 · first_quarter · Q1
To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2020 · fourth_quarter · Q4
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2020 · third_quarter · Q3
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2020 · second_quarter · Q2
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2020 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2019 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2019 · third_quarter · Q3
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2019 · second_quarter · Q2
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2019 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2018 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2018 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2018 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2018 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2017 · fourth_quarter · Q4
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2017 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2017 · second_quarter · Q2
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2017 · first_quarter · Q1
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2016 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2016 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2016 · second_quarter · Q2
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2016 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2015 · fourth_quarter · Q4
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2015 · third_quarter · Q3
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2015 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2015 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2014 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2014 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2014 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2014 · first_quarter · Q1
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2013 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2013 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2013 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2013 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2012 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2012 · third_quarter · Q3
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2012 · second_quarter · Q2
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regardsing WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2012 · first_quarter · Q1
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
FDA regulation of tobacco products, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2011 · fourth_quarter · Q4
FDA regulation of tobacco products, PL111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regardingWTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2011 · third_quarter · Q3
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2011 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2011 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2010 · fourth_quarter · Q4
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2010 · third_quarter · Q3
To ensure that FDA regulation of tobacco products is constituent with U.S. trade obligations regarding WTO-permissable restrictions on trade. PL 111-31.
FDA regulation of tobacco products, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2010 · second_quarter · Q2
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2010 · first_quarter · Q1
FDA regulation of tobacco products, PL 111-31.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2009 · fourth_quarter · Q4
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. PL 111-31.
FDA regulation of tobacco products, PL 111-31.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2009 · third_quarter · Q3
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1256.
FDA regulation of tobacco products, H.R. 1256.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2009 · second_quarter · Q2
FDA regulation of tobacco products, H.R 1256.
To ensure that FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1256.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2009 · first_quarter · Q1
FDA regulation of tobacco products, H.R. 1256.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1256.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2008 · fourth_quarter · Q4
FDA regulation of tobacco products, H.R. 1108, S. 625.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissable restrictions on trade. H.R. 1108 and S. 625.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2008 · third_quarter · Q3
FDA regulation of tobacco products, H.R. 1108, S. 625.
To ensure that proposed FDA regulation of tobacco products is consistent with U.S. trade obligations regarding WTO-permissible restrictions on trade. H.R. 1108 and S. 625.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2008 · second_quarter · Q2
To ensure that proposed FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade. H.R. 1108 and S.625.
FDA regulation of tobacco products, H.R. 1108, S.625
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2008 · first_quarter · Q1
FDA regulation of tobacco products, H.R. 1108, S.625
To ensure that proposed FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade. H.R.1108 and S.625.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPECIALTY TOBACCO COUNCIL INC via SPECIALTY TOBACCO COUNCIL, INC.
2008 · first_quarter · RR
FDA Regulation of Tobacco